Product Information
BACITRACIN-POLYMYXIN EYE OINT is a generic product labeled by Bausch & Lomb Incorporated, priced at $2.7898 per GM under NDC 24208055555. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jan 26, 1995.
Strength
500; 10000 [USP'U]/g; [USP'U]/g
Manufacturer
Bausch & Lomb IncorporatedNDC
24208055555
Classification
Generic
Dosage Form
OINTMENT
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BACITRACIN ZINC; POLYMYXIN B SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA064046FDA Approved
1/26/1995
On Market Since
4/25/2008
Pharmacological Classes
Price Statistics
The NADAC for BACITRACIN-POLYMYXIN EYE OINT has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 15.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7898 per GM |
|---|---|
| All-time high | $3.8331 (Apr 15, 2015) |
| All-time low | $1.7781 (Jul 17, 2024) |
| 52-week high | $3.0278 |
| 52-week low | $2.6947 |
| Median price | $3.0714 |
| Average price | $3.0638 |
| Largest weekly change | +53.8% (Aug 21, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BACITRACIN-POLYMYXIN EYE OINT?
The current National Average Drug Acquisition Cost (NADAC) for BACITRACIN-POLYMYXIN EYE OINT, manufactured by Bausch & Lomb Incorporated, is $2.7898 per GM (NDC 24208055555), effective Aug 19, 2026.
How has the price of BACITRACIN-POLYMYXIN EYE OINT changed over time?
Over the history we have for it, the NADAC for BACITRACIN-POLYMYXIN EYE OINT has declined 15.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BACITRACIN-POLYMYXIN EYE OINT?
Since Nov 28, 2013, the NADAC for BACITRACIN-POLYMYXIN EYE OINT has ranged from a low of $1.7781 (Jul 17, 2024) to a high of $3.8331 (Apr 15, 2015), with a median of $3.0714 per GM.
Are there cheaper alternatives to BACITRACIN-POLYMYXIN EYE OINT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HM DOUBLE ANTIBIOTIC OINTMENT, is $0.1066 per GM — about 96% below BACITRACIN-POLYMYXIN EYE OINT.
Who manufactures BACITRACIN-POLYMYXIN EYE OINT?
BACITRACIN-POLYMYXIN EYE OINT (NDC 24208055555) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.